ARCHIVE

GENERAL INFORMATION

American Journal of Innovative Research & Applied Sciences

ResearchBib, Google Scholar, SIS database, i.f.s.i.j, Scribd, IISJ, Eurasian Scientific Journal Index (ESJI), Indianscience.in, arastirmax, Directory of Research Journals Indexing, Pak Academic Sesearch, AcademicKeays, CiteSeerX, UDL Library, CAS Abstracts, J-Gate, WorldCat, Scirus, IET Inspec Direct, and getCited

Indexed by:

| HOME || ABOUT US || ARCHIVES || AIMS AND SCOP || AUTHORS || REVIEW|| SUBMIT MANUSCRIPT || EDITORIAL BOARD || CONTACT US |

| IMPACT FACTOR AND INDEXING | | PUBLICATION FEE |

| ARTICLES | Am. J. innov. res. appl. sci. Volume 8, Issue 6, Pages 276-281 (June 2019)

Research Article

American Journal of innovative
Research & Applied Sciences

ISSN 2429-5396 (Online)
OCLC Number: 920041286

| JUNE 8 | N° 6 | 2019 |

ABSTRACT

Background: Hepatitis E virus (HEV) infection in pregnant women during the third trimester is commonly associated to fatal outcome risk. In Burkina Faso, previous epidemiological studies showed pregnant women was marginally exposed/protected to/from this virus (10.6 to 11.6% seroprevalence) in 2010-2014. Objectives: This study aim to update our knowledge of HEV risk factor in this population in 2017. Methods: From July to December 2017, 90 pregnant women were recruited at the Samandin Medical Center. Demographic data were retrieved and Anti-HEV IgM and IgG detection tests were performed using commercial ELISA kits (Wantai, Beijing, China). Results: HEV IgG antibodies were detected in 55.6% (50/90; 95% CI: [45.3-65.8]) of the pregnant women. The seroprevalence seems to increase with age from 33% (<20 years of age) to 71.4% (30–36 years) p = 0.0501. There was no significant association between anti-HEV antibody seroprevalence rate with other risk factors. Conclusion: In 2017, we found a significant higher HEV IgG prevalence than the one observed among pregnant women in 2012. Identification of the source of this increase thus deserves new study. More importantly, a recall of hygiene rules before and during pregnancy is urgently needed to avoid numerous at risk new HEV infection in this population as we have no idea of the current origin (food, water, HEV genotype involved) of this increase of HEV exposition.
Keywords: Hepatitis E virus, pregnant women, co-infection, risk factors, Burkina Faso.